Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Ahern

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2011
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivorsThomas P Ahern, Mariann Christensen, Deirdre P Cronin-Fenton, et al.
Breast Cancer Research : BCR|November 5, 2021
Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control studyLindsay J Collin, Maret L Maliniak, Deirdre P Cronin-Fenton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2020
Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal WomenLindsay J Collin, Deirdre P Cronin-Fenton, Thomas P Ahern, et al.
Breast Cancer Research and Treatment|May 14, 2025
Genetic variants in tamoxifen metabolism and early treatment discontinuation among premenopausal breast cancer patientsKirsten M Woolpert, Thomas P Ahern, James W Baurley, et al.
Epidemiology (Cambridge, Mass.)|August 7, 2024
The Population-level Effect of Adjuvant Therapies on Breast Cancer Recurrence: Application of the Trend-in-Trend DesignLindsay J Collin, Lance A Waller, Deirdre P Cronin-Fenton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2017
Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 StudySigne Borgquist, Anita Giobbie-Hurder, Thomas P Ahern, et al.
Acta Oncologica (Stockholm, Sweden)|November 1, 2019
17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based studyLindsay J Collin, Sinna P Ulrichsen, Thomas P Ahern, et al.
Breast Cancer Research : BCR|December 30, 2025
17β-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in DenmarkLindsay J Collin, Kirsten M Woolpert, Anders Kjaersgaard, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 15, 2020
Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer PatientsThomas P Ahern, Lindsay J Collin, James W Baurley, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Early adipose tissue wasting in a novel preclinical model of human lung cancer cachexiaDeena B Snoke, Jos L van der Velden, Emma R Bellafleur, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2011
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivorsThomas P Ahern, Mariann Christensen, Deirdre P Cronin-Fenton, et al.
Breast Cancer Research : BCR|November 5, 2021
Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control studyLindsay J Collin, Maret L Maliniak, Deirdre P Cronin-Fenton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2020
Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal WomenLindsay J Collin, Deirdre P Cronin-Fenton, Thomas P Ahern, et al.
Breast Cancer Research and Treatment|May 14, 2025
Genetic variants in tamoxifen metabolism and early treatment discontinuation among premenopausal breast cancer patientsKirsten M Woolpert, Thomas P Ahern, James W Baurley, et al.
Epidemiology (Cambridge, Mass.)|August 7, 2024
The Population-level Effect of Adjuvant Therapies on Breast Cancer Recurrence: Application of the Trend-in-Trend DesignLindsay J Collin, Lance A Waller, Deirdre P Cronin-Fenton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2017
Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 StudySigne Borgquist, Anita Giobbie-Hurder, Thomas P Ahern, et al.
Acta Oncologica (Stockholm, Sweden)|November 1, 2019
17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based studyLindsay J Collin, Sinna P Ulrichsen, Thomas P Ahern, et al.
Breast Cancer Research : BCR|December 30, 2025
17β-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in DenmarkLindsay J Collin, Kirsten M Woolpert, Anders Kjaersgaard, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 15, 2020
Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer PatientsThomas P Ahern, Lindsay J Collin, James W Baurley, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Early adipose tissue wasting in a novel preclinical model of human lung cancer cachexiaDeena B Snoke, Jos L van der Velden, Emma R Bellafleur, et al.
Pageof 11